Company: HMDCF
Filing Date: 2025-03-19
Form Type: 20-F
Source: 0001410578-25-000377
Chunk: 85

Company: HUTCHMED (China) Ltd
Filing Date: 2025-03-19
Form: 20-F
Item: Item 1
Chunk 85
---
 our competitive business position and harm our business prospects.

Table of Contents

If our, our collaboration partners’ or our joint ventures’ products or drug candidates infringe the intellectual property rights of third parties, we and they may incur substantial liabilities, and we and they may be unable to sell these products.

Our commercial success depends significantly on our, our collaboration partners and our joint ventures’ ability to operate without infringing the patents and other proprietary rights of third parties. In the PRC, invention patent applications are generally maintained in confidence until their publication 18 months from the filing date. The publication of discoveries in the scientific or patent literature frequently occurs substantially later than the date on which the underlying discoveries were made and invention patent applications are filed. Even after reasonable investigation, we may not know with certainty whether any third-party may have filed a patent application without our knowledge while we or our joint ventures are still developing or producing that product. While the success of pending patent applications and applicability of any of them to our or our joint ventures’ programs are uncertain, if asserted against us or them, we could incur substantial costs and we or they may have to:

  obtain licenses, which may not be available on commercially reasonable terms, if at all;  
 ────────────────────────────────────────────────────────────────────────────────────────────

  redesign products or processes to avoid infringement; and  

  stop producing products using the patents held by others, which could cause us or them to lose the use of one or more of our or their products.  

To date, we, our collaboration partners and our joint ventures have not received any material claims of infringement by any third parties. If a third-party claims that we, our collaboration partners or our joint ventures infringe its proprietary rights, any of the following may occur:

  we, our collaboration partners or our joint ventures may have to defend litigation or administrative proceedings that may be costly whether we or they win or lose, and which could result in a s...  
 ────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────

  we, our collaboration partners or our joint ventures may become liable for substantial damages for past infringement if a court decides that our technology infringes a third-party ’ s intellect...  
 ────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────

  a court may prohibit us, our collaboration partners or our joint ventures from producing